Ranked No. 3 globally for cancer by Newsweek, with 97.6% breast cancer survival and CAR-T cell therapy and proton therapy for complex tumours.
Yes. Submit your diagnosis, imaging, and medical history through My 1Health before you travel.
The SMC oncology team confirms whether treatment is appropriate and outlines the expected approach, giving you clinical clarity before any travel costs are incurred.
Reach Samsung Medical Centre's cancer team through My 1Health.
Share your diagnosis, recent scans or pathology reports, and a brief medical summary to begin. The SMC oncology team reviews your case and provides the treatment plan and estimate.
SMC's 5-year survival rates consistently outperform both Korean national averages and US SEER benchmarks, based on published outcomes from 2008 to 2022.
Stay duration depends on your treatment type:
Your coordinator provides a specific itinerary once the oncology team confirms your plan.
There is no fixed price. Cost depends on your cancer type, specific procedures, length of stay, and individual clinical plan. Once My 1Health submits your case and the oncology team reviews it, a personalised estimate is prepared. An 80% deposit is required before admission for self-pay international patients.
Samsung Medical Centre treats 17+ cancer types across dedicated oncology centres, welcoming patients from 120+ countries. Adults and children are both treated.
Conditions include breast, lung, colorectal, gastric, liver, brain tumours, prostate, pancreatic, cervical, and blood cancers (leukaemia, lymphoma, myeloma), plus rare cancers including neuroendocrine tumours and sarcoma. CAR-T cell therapy, proton therapy, and BMT are all available to eligible international patients.